Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-16-121185

President & CEO acquired 17,666 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Mohan Pankaj · President & CEO

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2016-05-11 Conversion : show line 1 in the form +17,666 39,405 I

Table II: Derivative

1 line
Date Transaction Shares Exercise Owned after D/I
2016-05-18 Conversion : show line 2 in the form Series A Preferred Stock −106 $0.00 0 I
Loading xslF345X03/doc4.xml…